Two new 22-membered macrolides from Streptomyces sp. HU210

Area of Science:

• Natural Product Chemistry
• Microbiology
• Pharmacology

Background:

• Streptomyces species are a prolific source of bioactive secondary metabolites.
• Macrolide compounds are known for diverse biological activities, including cytotoxicity.

Purpose of the Study:

• To isolate and characterize novel macrolide metabolites from Streptomyces sp. HU210.
• To evaluate the cytotoxic potential of the isolated compounds against human cancer cell lines.

Main Methods:

• Fermentation of Streptomyces sp. HU210.
• Isolation and purification of metabolites using chromatographic techniques.
• Structure elucidation via Nuclear Magnetic Resonance (NMR) spectroscopy and High-Resolution Electrospray Ionization Mass Spectrometry (HRESIMS).
• Cytotoxicity assays against K562 (leukemia) and A549 (lung carcinoma) cell lines.

Main Results:

• Two new 22-membered macrolide metabolites, designated phthoramycins B (1) and C (2), were successfully isolated.
• The structures of compounds 1 and 2 were fully elucidated using comprehensive spectroscopic data.
• Both phthoramycins B and C demonstrated moderate cytotoxic activity against the tested human leukemia and lung carcinoma cell lines.

Conclusions:

• The study successfully identified and characterized two novel macrolide compounds, phthoramycins B and C.
• These findings contribute to the growing library of natural products with potential anticancer applications.
• Further investigation into the mechanism of action and structure-activity relationship of these compounds is warranted.